Trial Profile
Adherence to denosumab treatment and affecting factors for regular drug administration in postmenopausal women with osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 21 Aug 2015 New trial record